Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%1.65%18.34x1.26x2.12x8.59x11.67x 8.31B
1.84%2.03%25.6x3.95x5.49x16.42x19.27x 76.69B
0.5%0.53%19.23x1.84x3.76x10.99x12.7x 59.99B
-.--%-.--%54.57x6.12x13.13x31.17x42.57x 54.72B
0.83%0.85%32.58x3.01x4.92x16.24x24.38x 37.99B
-.--%-.--%11.88x1.07x2.2x6.58x6.73x 19.67B
-.--%0.01%304.77x8.34x10.1x139.01x372.69x 17.54B
-.--%-.--%15.18x2.62x2.08x7.16x7.06x 13.28B
-.--%-.--%-3.33x1.65x0.91x14.64x4.93x 13.01B
-.--%-.--%17.12x1.74x3.04x10.32x11.85x 11.14B
0.04%0.05%581.4x - - - - 10.5B
-.--%-.--%21.56x2.22x3.81x10.37x16.16x 10.29B
-.--%-.--%-15.4x-4.52x23.2x-27.45x-22.07x 8.82B
1.02%1.7%9.73x2.87x3.49x7.64x16.86x 7.56B
0.67%0.88%27.61x1.53x2.11x20.08x21.88x 6.86B
-.--%-.--%19.09x1.35x4.47x14.4x16.2x 6.38B
Average 0.31% 0.48% 71.24x 2.34x 5.65x 19.08x 37.53x 22.67B
Weighted average by Cap. 0.59% 0.7% 55.13x 3.23x 6.18x 21.10x 36.64x
Biopharmaceuticals